FDA warned website All Ketamine HCL for selling unapproved, misbranded ketamine drugs online without prescriptions.
What happened
FDA reviewed the website www.allketaminehcl.com on February 27, 2026 (Establishment Identifier 3043544156) and found ketamine drug products offered for sale to U.S. consumers. One example is a product marketed as "Ketamax" 50mg, described on the site as an anesthetic used to put patients to sleep for surgery. FDA says the site sells these drugs without FDA approval and without requiring a prescription.
What FDA found
The company sells ketamine products that have no FDA-approved application, which is illegal for a new drug.
FD&C Act sections 301(d) and 505(a) (21 U.S.C. 331(d), 355(a))The product labeling does not give adequate directions for use, and as a prescription drug it cannot be labeled so a layperson could use it safely.
FD&C Act section 502(f)(1) (21 U.S.C. 352(f)(1))The company offers a prescription drug for sale without requiring a prescription from a licensed practitioner.
FD&C Act sections 503(b)(1) and 301(k) (21 U.S.C. 353(b)(1), 331(k))By offering these drugs for sale to U.S. consumers, the company causes misbranded drugs to enter interstate commerce.
FD&C Act section 301(a) (21 U.S.C. 331(a))
What FDA wants
FDA tells the company to stop offering unapproved and misbranded drugs for sale to U.S. consumers and to send a written response with the corrective steps taken and supporting documents. The reply is due within 15 business days of receiving the letter, citing reference number MARCS-CMS 725150.
Who should pay attention
- online pharmacies and websites selling ketamine or other prescription drugs
- telehealth providers and clinics offering ketamine treatment
- compounders and distributors of ketamine products
This is a summary. Read the original letter on fda.gov.